Curanex Pharmaceuticals Inc financial data

Symbol
CURX on Nasdaq
Location
Jericho, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 17 Nov 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27,750,000 shares
Common Stock, Shares, Outstanding 28,340,812 shares
Common Stock, Value, Issued $2,834 USD
Weighted Average Number of Shares Outstanding, Basic 25,599,673 shares 967%
Weighted Average Number of Shares Outstanding, Diluted 25,599,673 shares 967%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $677,474 USD
General and Administrative Expense $273,853 USD 194%
Operating Income (Loss) $951,327 USD -920%
Net Income (Loss) Attributable to Parent $954,059 USD -947%
Earnings Per Share, Basic -0.04 USD/shares 0%
Earnings Per Share, Diluted -0.04 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,800,000 USD
Assets, Current $14,417,759 USD
Operating Lease, Right-of-Use Asset $60,398 USD
Assets $14,478,157 USD
Accounts Payable, Current $114,489 USD
Accrued Liabilities, Current $10,316 USD
Liabilities, Current $185,955 USD
Liabilities $185,955 USD
Retained Earnings (Accumulated Deficit) $1,774,437 USD
Stockholders' Equity Attributable to Parent $14,292,202 USD 2190%
Liabilities and Equity $14,478,157 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 475,000,000 shares
Common Stock, Shares, Issued 28,340,812 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Deferred Tax Assets, Valuation Allowance $241,918 USD
Deferred Tax Assets, Gross $241,918 USD
Operating Lease, Liability $61,150 USD
Lessee, Operating Lease, Liability, to be Paid $64,564 USD
Operating Lease, Liability, Current $61,150 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $46,958 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,414 USD
Deferred Tax Assets, Operating Loss Carryforwards $241,918 USD
Preferred Stock, Shares Issued 1,000,000 shares
Preferred Stock, Shares Authorized 25,000,000 shares
Preferred Stock, Shares Outstanding 1,000,000 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares